Summit Therapeutics Inc. Interest Income (Expense), Nonoperating, Net
Summit Therapeutics Inc. (SMMT) reported Interest Income (Expense), Nonoperating, Net of -$55.00 thousand for the 3-month period ending 2020-06-30, per its 8-K filed 2020-09-29.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2020-09-29
- Summit Therapeutics Inc. interest income (expense), nonoperating, net for the quarter ending 2020-06-30 was -$55.00K.
- Summit Therapeutics Inc. interest income (expense), nonoperating, net for the quarter ending 2019-06-30 was -$79.00K.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 11 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2020-06-30 | -$55.00K 8-K · filed 2020-09-29 | -$120.00K 8-K · filed 2020-09-29 | ||
| 2019-12-31 | -$286.00K 8-K · filed 2020-09-29 | |||
| 2019-06-30 | -$79.00K 8-K · filed 2020-09-29 | -$156.00K 8-K · filed 2020-09-29 | ||
| 2019-01-31 | -$615.00K 8-K · filed 2020-09-29 | |||
| 2018-01-31 | -$1.54M 8-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |